Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Respiratory Tract Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.925 | 0.120 | 17 | 47299308 | missense variant | G/A | snv | 4.0E-06 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.080 | 17 | 47256377 | intron variant | A/G | snv | 0.65 |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.790 | 0.240 | 17 | 47311220 | 3 prime UTR variant | T/A;G | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
|
1.000 | 0.040 | 17 | 47300211 | intron variant | G/T | snv | 0.18 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 17 | 47252316 | upstream gene variant | G/A | snv | 0.23 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 17 | 47253717 | upstream gene variant | G/C | snv | 0.23 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.882 | 17 | 47252111 | upstream gene variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 17 | 47252111 | upstream gene variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 17 | 47252111 | upstream gene variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 17 | 47252111 | upstream gene variant | C/A;T | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
17 | 47299316 | stop gained | C/T | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||||
|
17 | 47286394 | missense variant | A/G | snv |
|
Hemic and Lymphatic Diseases | 0.700 | 0 | |||||||||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2005 | 2006 | ||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.030 | 0.667 | 3 | 2005 | 2010 | ||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2005 | 2016 | ||||||
|
1.000 | 0.080 | 17 | 47292176 | missense variant | C/A | snv |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.882 | 0.160 | 17 | 47310917 | 3 prime UTR variant | A/G | snv | 9.4E-02 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.020 | 1.000 | 2 | 2011 | 2014 | ||||||
|
0.683 | 0.480 | 17 | 47283364 | missense variant | T/C | snv | 0.12 | 0.13 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2009 | 2015 | ||||||
|
0.882 | 0.160 | 17 | 47310917 | 3 prime UTR variant | A/G | snv | 9.4E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.790 | 0.240 | 17 | 47311220 | 3 prime UTR variant | T/A;G | snv |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 |